Medical Research News

RSS

SARS-CoV-2 variants of concern more virulent than the native strain of the virus

A large study from Ontario confirms that SARS-CoV-2 variants of concern (VOCs), especially the Delta variant, are more virulent than the native strain of the virus, increasing people's risk of hospitalization, admission to the intensive care unit (ICU) and death due to COVID-19.

5 Oct 2021

Study: Six out of ten patients with “red flag” cancer symptoms not referred for urgent investigation

Six out of ten patients who show common "alarm" symptoms for cancer are not referred for urgent investigation, a largescale new study has revealed.

5 Oct 2021

A review of COVID data reporting in Africa

An international team of scientists has recently investigated how African countries report and share data related to the Coronavirus disease 2019 (COVID-19) pandemic. They have found that African countries use distinct reporting systems that include social media posts, website updates, situation reports, press releases, and online dashboards. A detailed report of the findings is currently available on the medRxiv* preprint server.

5 Oct 2021

Study identifies specific small RNA molecule that can reduce levels of cancer-promoting gene

In a recent study published in CANCER RESEARCH , a team led by researchers at Tokyo Medical and Dental University (TMDU) identified a specific small RNA molecule, called a microRNA (miRNA or miR), that has the potential to be used as an anti-cancer therapeutic.

5 Oct 2021

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Researchers in the United States have shown that a compound currently used to treat cystinosis exhibits broad antiviral activity against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 Oct 2021

Cesarean birth may not be the safest mode of delivery for transplant patients

New research suggests that cesarean births for transplant patients carry higher risks to baby and mother.

5 Oct 2021

Fatal opioid overdoses four times more likely in the first two days after hospital discharge

The period after hospital discharge is a high-risk time for people who use illicit opioids such as heroin, according to new research publishing October 5th in the open access journal PLOS Medicine.

5 Oct 2021

Plasmid DNA vaccines induce effective antibody responses against SARS-CoV-2 in mice

Researchers in the United States and China have developed plasmid DNA immunogens that induce effective antibody responses in mice against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 Oct 2021

Hollings Cancer Center researcher awarded NCI grant to pursue early investigator studies in leukemia

MUSC Hollings Cancer Center researcher Haizhen (Jen) Wang, Ph.D., was awarded a five-year $344,000 per year grant by the National Cancer Institute to pursue her early investigator studies in leukemia.

5 Oct 2021

COVID-19 survivors under 40 more likely to recover from smell and taste loss, study finds

Sense of smell or taste returns within six months for 4 out of every 5 COVID-19 survivors who have lost these senses, and those under 40 are more likely to recover these senses than older adults, an ongoing Virginia Commonwealth University study found.

5 Oct 2021

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found.

5 Oct 2021

Plant-derived compound can be beneficial in protecting the brain against Alzheimer’s disease pathology

Fenchol, a natural compound abundant in some plants including basil, can help protect the brain against Alzheimer's disease pathology, a preclinical study led by University of South Florida Health (USF Health) researchers suggests.

5 Oct 2021

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

A new study reports on the results of phase III clinical trial on the safety and efficacy of the AstraZeneca-Oxford COVID-19 vaccine.

5 Oct 2021

Structural differences in the brain may explain why siblings differ in risk of developing conduct disorder

Structural differences in the area of the brain responsible for decision making could explain why two siblings living in the same family might differ in their risk of developing the condition conduct disorder.

5 Oct 2021

A possible protective genetic polymorphism in COVID-19

A new study discusses the role of a mucin gene enhancer on the clinical phenotype of the COVID-19.

5 Oct 2021

Two meters physical distancing is not enough without masks to prevent the spread of COVID-19

To prevent the spread of COVID-19 indoors, the two metres physical distancing guideline is not enough without masks, according to researchers from Quebec, Illinois, and Texas.

5 Oct 2021

Urban older women who participated in an exercise intervention were healthier than non-participants

Urban participants in an exercise intervention for older women in Kuopio, eastern Finland, were healthier and had better functional capability at baseline than non-participants and uninvited rural women, according to new findings from the Kuopio Fall Prevention Study.

5 Oct 2021

Medical Research News

SARS-CoV-2 variants of concern more virulent than the native strain of the virus

Study: Six out of ten patients with “red flag” cancer symptoms not referred for urgent investigation

A review of COVID data reporting in Africa

Study identifies specific small RNA molecule that can reduce levels of cancer-promoting gene

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Cesarean birth may not be the safest mode of delivery for transplant patients

Fatal opioid overdoses four times more likely in the first two days after hospital discharge

Plasmid DNA vaccines induce effective antibody responses against SARS-CoV-2 in mice

Hollings Cancer Center researcher awarded NCI grant to pursue early investigator studies in leukemia

COVID-19 survivors under 40 more likely to recover from smell and taste loss, study finds

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

Plant-derived compound can be beneficial in protecting the brain against Alzheimer’s disease pathology

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

Structural differences in the brain may explain why siblings differ in risk of developing conduct disorder

A possible protective genetic polymorphism in COVID-19

Two meters physical distancing is not enough without masks to prevent the spread of COVID-19

Urban older women who participated in an exercise intervention were healthier than non-participants

Fertility treatment compromised in women with undiagnosed endometriosis

Anti-nucleocapsid SARS-Cov-2 antibodies wane over time in long-term care facilities

SARS-CoV-2 beta variant elicits variant specific and cross-reactive antibodies

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News